{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:54:25Z","timestamp":1790996065746,"version":"4.1.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The treatment of bipolar disorder (BD) remains challenging. The study evaluated the impact of the hypothalamic\u2013pituitary\u2013adrenal (HPA) axis\/hypothalamic\u2013pituitary-thyroid (HPT) axis and glucose metabolism on the clinical outcomes in patients with bipolar depression (BD-D) and manic bipolar (BD-M) disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The research design involved a longitudinal prospective study. A total of 500 BD patients aged between 18 and 65\u2009years treated in 15 hospitals located in Western China were enrolled in the study. The Young Mania Rating Scale (YMRS) and Montgomery and Asberg Depression Rating Scale (MADRS) were used to assess the BD symptoms. An effective treatment response was defined as a reduction in the symptom score of more than 25% after 12\u2009weeks of treatment. The score of symptoms was correlated with the homeostatic model assessment of insulin resistance (HOMA-IR) index, the HPA axis hormone levels (adrenocorticotropic hormone (ACTH) and cortisol), and the HPT axis hormone levels (thyroid stimulating hormone (TSH), triiodothyronine (T3), thyroxine (T4), free triiodothyronine (fT3), and free thyroxine (fT4)).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the BD-M group, the YMRS was positively correlated with baseline T4 (\n                      <jats:italic>r<\/jats:italic>\n                      =\u20090.349,\n                      <jats:italic>p<\/jats:italic>\n                      =\u20090.010) and fT4 (\n                      <jats:italic>r<\/jats:italic>\n                      =\u20090.335,\n                      <jats:italic>p<\/jats:italic>\n                      =\u20090.013) and negatively correlated with fasting insulin (\n                      <jats:italic>r<\/jats:italic>\n                      = \u22120.289,\n                      <jats:italic>p<\/jats:italic>\n                      =\u20090.013). The pre-treatment HOMA-IR was significantly correlated with adverse course (\n                      <jats:italic>p<\/jats:italic>\n                      =\u20090.045, OR\u2009=\u20090.728). In the BD-D group, the baseline MADRS was significantly positively correlated with baseline fT3 (\n                      <jats:italic>r<\/jats:italic>\n                      =\u20090.223,\n                      <jats:italic>p<\/jats:italic>\n                      =\u20090.032) and fT4 (\n                      <jats:italic>r<\/jats:italic>\n                      =\u20090.315,\n                      <jats:italic>p<\/jats:italic>\n                      =\u20090.002), while baseline T3 (\n                      <jats:italic>p<\/jats:italic>\n                      =\u20090.032, OR\u2009=\u20095.071) was significantly positively related to treatment response.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The HPT axis and glucose metabolism were closely associated with clinical outcomes at 12\u2009weeks in both BD-D and BD-M groups. If confirmed in further longitudinal studies, monitoring T3 in BD-D patients and HOMA-IR for BD-M could be used as potential treatment response biomarkers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2024.1275177","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T23:21:38Z","timestamp":1706052098000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["The association between neuroendocrine\/glucose metabolism and clinical outcomes and disease course in different clinical states of bipolar disorders"],"prefix":"10.3389","volume":"15","author":[{"given":"Xu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/0004867420979353","article-title":"The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders","volume":"55","author":"Malhi","year":"2021","journal-title":"Aust N Z J Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S2215-0366(18)30511-X","article-title":"Prevalence of mental disorders in China: a cross-sectional epidemiological study","volume":"6","author":"Huang","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40345-019-0160-1","article-title":"Bipolar depression: a major unsolved challenge","volume":"8","author":"Baldessarini","year":"2020","journal-title":"Int J Bipolar Disord"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.4088\/JCP.08r04505","article-title":"Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature","volume":"70","author":"Goldstein","year":"2009","journal-title":"Dis Nerv Syst"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1177\/070674370304800706","article-title":"The cortisol awakening response in bipolar illness: a pilot study","volume":"48","author":"Deshauer","year":"2003","journal-title":"Can J Psychiatr"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0022-3956(99)00014-X","article-title":"The dexamethasone\/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness","volume":"33","author":"Rybakowski","year":"1999","journal-title":"J Psychiatr Res"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fendo.2014.00139","article-title":"Crossover of the hypothalamic pituitary-adrenal\/interrenal, -thyroid, and -gonadal axes in testicular development","volume":"5","author":"Casta\u00f1eda Cort\u00e9s","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ygcen.2005.10.014","article-title":"Role of corticotropinreleasing hormone as a thyrotropin-releasing factor in nonmammalian vertebrates","volume":"146","author":"De Groef","year":"2006","journal-title":"Gen Comp Endocrinol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.1365-2826.2008.01774.x","article-title":"The thyroid-brain interaction in thyroid disorders and mood disorders","volume":"20","author":"Bauer","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0193-953X(05)70005-8","article-title":"Psychoneuroendocrinology of mood disorders: the hypothalamic-pituitarythyroid axis","volume":"21","author":"Hendrick","year":"1998","journal-title":"Psychiatr Clin N Am"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1136\/bmj.302.6782.923","article-title":"Thyroid dysfunction and affective illness","volume":"302","author":"Szabadi","year":"1991","journal-title":"Br Med J"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(02)07450-0","article-title":"Bipolar disorder","volume":"359","author":"M\u00fcller-Oerlinghausen","year":"2002","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/306367","article-title":"Thyroid functions and bipolar affective disorder","volume":"2011","author":"Chakrabart","year":"2011","journal-title":"J Thyroid Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1089\/thy.2005.15.700","article-title":"Increased risk of developing affective disorder in patients with hypothyroidism: a register-based study","volume":"15","author":"Thomsen","year":"2005","journal-title":"Thyroid"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/j.euroneuro.2022.07.214","article-title":"Local patterns of shared genetics and a genetic latent factor of insulin resistance and neuropsychiatric multimorbidity","volume":"63","author":"Fanelli","year":"2022","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.euroneuro.2022.04.011","article-title":"Depression, antidepressants, and insulin resistance: which link?","volume":"60","author":"Fanelli","year":"2022","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"105298","DOI":"10.1016\/j.neubiorev.2023.105298","article-title":"Clinical insights into the cross-link between mood disorders and type 2 diabetes: a review of longitudinal studies and Mendelian randomisation analyses","volume":"152","author":"Possidente","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1186\/s12888-022-04163-z","article-title":"Temporally ordered associations between type 2 diabetes and brain disorders \u2013 a Danish register-based cohort study","volume":"22","author":"Wimberley","year":"2022","journal-title":"BMC Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41398-022-01817-0","article-title":"Insulinopathies of the brain? Genetic overlap between somatic insulin-related and neuropsychiatric disorders","volume":"12","author":"Fanelli","year":"2022","journal-title":"Transl Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.biopsych.2013.11.007","article-title":"Type 2 diabetes mellitus: a potentially modifiable risk factor for neurochemical brain changes in bipolar disorders","volume":"77","author":"Hajek","year":"2015","journal-title":"Biol Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1038\/npp.2014.148","article-title":"Insulin resistance, diabetes mellitus and brain structure in bipolar disorders","volume":"39","author":"Hajek","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1176\/appi.ajp.159.1.116","article-title":"Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function","volume":"159","author":"Cole","year":"2002","journal-title":"Am J Psychiatr"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/07853890.2012.687835","article-title":"The relationship between bipolar disorder and type 2 diabetes: more than just co-morbid disorders","volume":"45","author":"Calkin","year":"2013","journal-title":"Ann Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/acps.12194","article-title":"\u201cIs bipolar disorder an endocrine condition?\u201d Glucose abnormalities in bipolar disorder","volume":"129","author":"Garcia-Rizo","year":"2014","journal-title":"Acta Psychiatr Scand"},{"key":"ref25","unstructured":"2010"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jpsychires.2005.05.002","article-title":"Validation of an IVRS version of the MADRS","volume":"40","author":"Mundt","year":"2006","journal-title":"J Psychiatr Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0025-7753(02)73419-2","article-title":"Spanish version of a scale for the assessment of mania: validity and reliability of the Young mania rating scale","volume":"119","author":"Colom","year":"2002","journal-title":"Med Clin"},{"key":"ref28","first-page":"195","volume-title":"Consensus of identification and optimize therapeutic scheme of bipolar affective disorder and its atypical symptoms","author":"Xueli","year":"2017"},{"key":"ref29","first-page":"1069","article-title":"TESS (treatment emergent symptom scale-write-in)","volume":"21","year":"1985","journal-title":"Psychopharmacol Bull"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1021\/cr020373d","article-title":"Electrochemiluminescence (ECL)","volume":"104","author":"Richter","year":"2004","journal-title":"Chem Rev"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1172\/JCI105955","article-title":"Radioimmunoassay of ACTH in plasma","volume":"47","author":"Berson","year":"1968","journal-title":"J Clin Investig"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.2337\/diacare.24.2.362","article-title":"Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes","volume":"24","author":"Katsuki","year":"2001","journal-title":"Diabetes Care"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1600-0447.2008.01343.x","article-title":"Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebocontrolled bipolar I maintenance studies","volume":"120","author":"Frye","year":"2009","journal-title":"Acta Psychiatr Scand"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.psyneuen.2019.05.013","article-title":"Neuroendocrine abnormalities associated with untreated first episode patients with major depressive disorder and bipolar disorder","volume":"107","author":"Feng","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/PSY.0b013e31820ad12b","article-title":"Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research","volume":"73","author":"Stetler","year":"2011","journal-title":"Psychosom Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jad.2017.09.052","article-title":"Atypical depression and non-atypical depression: is HPA axis function a biomarker? A systematic review","volume":"233","author":"Juruena","year":"2018","journal-title":"J Affect Disord"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.psc.2005.01.005","article-title":"Hypothalamic-pituitary-adrenal axis and bipolar disorder","volume":"28","author":"Daban","year":"2005","journal-title":"Psychiatr Clin N Am"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1176\/ajp.141.5.619","article-title":"Psychiatric implications of basic and clinical studies with corticotropin-releasing factor","volume":"141","author":"Gold","year":"1984","journal-title":"Am J Psychiatr"},{"key":"ref39","volume-title":"Manic-depressive illness","author":"Goodwin","year":"2007"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/bdi.12163","article-title":"Female vulnerability for thyroid function abnormality in bipolar disorder: role of lithium treatment","volume":"16","author":"\u00d6zerdem","year":"2014","journal-title":"Bipolar Disord"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jpsychires.2014.12.016","article-title":"Subclinical hypothyroidism and neurocognitive functioning in bipolar disorder","volume":"61","author":"Martino","year":"2015","journal-title":"J Psychiatr Res"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ajp.2012.08.003","article-title":"Association between bipolar affective disorder and thyroid dysfunction","volume":"6","author":"Krishna","year":"2013","journal-title":"Asian J Psychiatr"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/00005053-198906000-00006","article-title":"Serum thyroxine levels in schizophrenic and affective disorder diagnostic subgroups","volume":"177","author":"Mason","year":"1989","journal-title":"Chicago J Nerv Ment Dis"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0022-3956(91)90011-x","article-title":"The prognostic significance of thyroid function in mania","volume":"25","author":"Joyce","year":"1991","journal-title":"J Psychiatr Res"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/00004583-199405000-00004","article-title":"Basal thyroid indices in adolescent depression and bipolar disorder","volume":"33","author":"Sokolov","year":"1994","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/00004714-200004000-00013","article-title":"Thyroid function and psychiatric morbidity in patients with manic disorder receiving lithium therapy","volume":"20","author":"Lee","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0022-3999(92)90028-z","article-title":"Disturbances in dexamethasone suppression test and lower availability of L-tryptophan and tyrosine in early puerperium and in women under contraceptive therapy","volume":"36","author":"Maes","year":"1992","journal-title":"J Psychosom Res"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1115\/1.2812393","article-title":"Thyroid hormones and the central nervous system in affective illness: interactions that may have clinical significance","volume":"121","author":"Bauer","year":"1988","journal-title":"Integr Psychiatry"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0006-3223(89)90148-0","article-title":"Serum thyroxine change and clinical recovery in psychiatric inpatients","volume":"25","author":"Southwick","year":"1989","journal-title":"Biol Psychiatry"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/mp.2014.186","article-title":"Levothyroxine effects on depressive symptoms and limbic glucose metabolism in bipolar disorder: a randomized, placebo-controlled positron emission tomography study","volume":"21","author":"Bauer","year":"2016","journal-title":"Mol Psychiatry"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s11064-014-1305-3","article-title":"Level of thyroid-stimulating hormone (TSH) in patients with acute schizophrenia, unipolar depression or bipolar disorder","volume":"39","author":"Wysokinski","year":"2014","journal-title":"Neurochem Res"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/YIC.0000000000000438","article-title":"Hyperthyroidism and depression: a clinical case of atypical thyrotoxicosis manifestation","volume":"38","author":"Chiera","year":"2023","journal-title":"Int Clin Psychopharmacol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1365-2265.2008.03352.x","article-title":"Thyroid function and the natural history of depression: findings from the Caerphilly prospective study (CaPS) and a meta analysis","volume":"70","author":"Williams","year":"2009","journal-title":"Clin Endocr"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000497182","article-title":"Correlation between intrinsic brain activity and thyroid-stimulating hormone level in unmedicated bipolar II depression","volume":"108","author":"Zhong","year":"2019","journal-title":"Neuroendocrinology"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jpsychires.2022.03.023","article-title":"Thyroid hormones disturbances, cognitive deficits and abnormal dynamic functional connectivity variability of the amygdala in unmedicated bipolar disorder","volume":"150","author":"Chen","year":"2022","journal-title":"J Psychiatr Res"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1176\/ajp.156.12.1909","article-title":"Association between lower mean serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients","volume":"156","author":"Frye","year":"1999","journal-title":"Am J Psychiatr"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jad.2006.10.012","article-title":"Free T4 index and clinical outcome in patients with depression","volume":"100","author":"Abulseoud","year":"2007","journal-title":"J Affect Disord"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0165-0327(95)00019-J","article-title":"The hypothalamicpituitary-thyroid axis in patients maintained on lithium prophylaxis for years: high triiodothyronine serum concentrations are correlated to the prophylactic efficacy","volume":"34","author":"Baumgartner","year":"1995","journal-title":"J Affect Disord"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/09540260902962107","article-title":"The functional neuroanatomy of bipolar disorder","volume":"21","author":"Cerullo","year":"2009","journal-title":"Int Rev Psychiatry"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/978-3-642-74034-3_35","article-title":"Marginal hypothyroidism in mental illness: preliminary assessments of prevalence and significance","volume":"1","author":"Prange","year":"1990","journal-title":"Neuropsychopharmacology"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1192\/bjp.bp.114.152850","article-title":"Insulin resistance and outcome in bipolar disorder","volume":"206","author":"Calkin","year":"2015","journal-title":"Br J Psychiatry"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1586\/ern.10.185","article-title":"Insulin dysfunction and allostatic load in bipolar disorder","volume":"11","author":"Brietzke","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1161\/CIRCRESAHA.107.165472","article-title":"Role of mitochondrial dysfunction in insulin resistance","volume":"102","author":"Kim","year":"2008","journal-title":"Circ Res"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"104927","DOI":"10.1016\/j.neubiorev.2022.104927","article-title":"The link between cognition and somatic conditions related to insulin resistance in the UK Biobank study cohort: a systematic review","volume":"143","author":"Fanelli","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/s0006-3223(98)00100-0","article-title":"Novel antipsychotics and new onset diabetes","volume":"44","author":"Wirshing","year":"1998","journal-title":"Biol Psychiatry"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/10673220600748486","article-title":"Side effects of atypical antipsychotics: extrapyramidal symptoms and the metabolic syndrome","volume":"14","author":"Shirzadi","year":"2006","journal-title":"Harv Rev Psychiatry"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/bdi.12423","article-title":"The prevalence and burden of bipolar disorder: findings from the global burden of disease study 2013","volume":"18","author":"Ferrari","year":"2016","journal-title":"Bipolar Disord"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1275177\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T23:21:44Z","timestamp":1706052104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1275177\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":67,"alternative-id":["10.3389\/fpsyt.2024.1275177"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2024.1275177","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,24]]},"article-number":"1275177"}}